Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDp Poland Regulatory News (DPP)

Share Price Information for Dp Poland (DPP)

Share Price is delayed by 15 minutes
Get Live Data
7.25    0.00 (0.00%)
Bid:
7.00
Ask:
7.50
Spread: 0.50 (7.143%)
Market Cap: £68.44m
DPP Live PriceLast checked at - London Stock Exchange

Intraday Dp Poland Share Chart

Holding(s) in Company

5 Jan 2015 13:32

RNS Number : 2881B
DP Poland PLC
05 January 2015
 



 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

DP Poland PLC

Sedol B3Q74M5 GB

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation:

Majedie Asset Management Limited

4. Full name of shareholder(s)  (if different from 3.):

5. Date of the transaction and date onwhich the threshold is crossed orreached:

30 December 2014

6. Date on which issuer notified:

31 December 2014

7. Threshold(s) that is/are crossed orreached:

Below 5%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB00B3Q74M51 Ordinary Shares

5,316,666

5,316,666

0

0%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

0

0%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

Majedie Asset Management Limited is a discretionary Fund Manager. It invests funds on behalf of its clients on a segregated basis as well as through sub-funds of its pooled vehicles, Majedie Asset Management Investment Fund Company and Majedie Asset Management (International) Investment Fund Company Plc. It is also the manager of the Majedie Institutional Trust.

14. Contact name:

Jo Mann

15. Contact telephone number:

020 7618 3939

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFVVLIIEIIE
Date   Source Headline
24th Jun 202611:01 amRNSResult of AGM
29th May 202612:00 pmRNS2025 Annual Report and Notice of 2026 AGM
28th May 20267:00 amRNSFinal Results 2025 and Investor Presentation
14th Apr 20267:00 amRNSQ1 2026 Trading Update
12th Mar 20267:00 amRNS-RYellowstone Advisory Private Investor Evening
9th Mar 20267:00 amRNSAppointment of Non-Executive Director
5th Feb 20267:00 amRNSBoard Changes
14th Jan 20267:00 amRNSFull Year Trading Update
27th Nov 20257:00 amRNSNew Financing Arrangements
20th Oct 20257:00 amRNSRenewal of Master Franchise Agreement
14th Oct 20257:00 amRNSQ3 2025 Trading Update
15th Sep 20257:00 amRNSInterim Results and Trading Update
12th Sep 20257:00 amRNSNotice of Results & Investor Presentation
24th Jul 20254:26 pmRNSResult of AGM
10th Jul 20257:00 amRNSTrading Update
30th Jun 202510:04 amRNS2024 Annual Report and Notice of AGM
27th Jun 20257:00 amRNSFinal Results 2024 and Investor Presentation
23rd May 20254:01 pmRNSTiming of Final Results
16th Apr 20257:00 amRNSTrading Update
10th Apr 202512:15 pmRNSHolding(s) in Company
1st Apr 20257:00 amRNSChange of Registered Office
27th Mar 20257:00 amRNSStrategic Acquisition
28th Feb 202512:15 pmRNSExercise of Options & TVR
16th Jan 20257:00 amRNSFull Year unaudited Trading Update for 2024
4th Nov 20247:00 amRNSTrading Update
4th Oct 202410:00 amRNSDirector/PDMR Dealing
17th Sep 20247:00 amRNSInterim Results & Trading Update
30th Aug 20247:00 amRNSNotice of Results and Investor Presentation
11th Jul 20247:00 amRNSTrading Update
27th Jun 20241:07 pmRNSResult of AGM
3rd Jun 20248:42 amRNSPosting of Annual Report & Notice of AGM
31st May 20247:00 amRNSFinal Results
20th May 20248:56 amRNSGrant of Options (Replacement)
29th Apr 202412:30 pmRNSGrant of Options
29th Apr 20247:00 amRNSTrading Update
25th Apr 20244:50 pmRNSExercise of Options & TVR
19th Apr 20241:21 pmRNSHolding(s) in Company
19th Apr 20249:57 amRNSDirector/PDMR Dealing
18th Apr 20241:40 pmRNSResult of General Meeting
16th Apr 20247:00 amRNSResult of Retail Offer
3rd Apr 20247:00 amRNSPublication of Circular
28th Mar 20244:01 pmRNSLaunch of Retail Offer
28th Mar 20244:00 pmRNSResult of Placing
28th Mar 202411:05 amRNSClose of Bookbuild
27th Mar 20244:45 pmRNSProposed Fundraise
16th Jan 20247:00 amRNSTrading Update
15th Nov 20237:00 amRNSBoard Changes
14th Nov 20237:00 amRNSTrading Update
10th Oct 20237:00 amRNSBoard Changes
26th Sep 20237:00 amRNSInterim Results & Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.